Literature DB >> 26846266

MicroRNA-96 Regulates Apoptosis by Targeting PDCD4 in Human Glioma Cells.

Qing-Qing Ma1, Jian-Ting Huang2, Yun-Gang Xiong1, Xiao-Yan Yang1, Ran Han1, Wang-Wen Zhu1.   

Abstract

Glioblastoma multiforme, the most common and aggressive form of primary brain tumor, presents a dismal prognosis. MicroRNAs play a critical role in the initiation, progression, and metastasis of cancer; however, the potential biological role of miRNAs in glioblastoma multiforme remains largely unknown. In our study, we found that microRNA-96 is upregulated in glioma tissues than in normal human brains. Transfection of microRNA-96 mimics into glioma cells significantly decreases apoptosis by suppressing PDCD4, a well-known tumor suppressor that is involved in apoptosis. In contrast, knockdown of microRNA-96 enhanced apoptosis. In vivo, microRNA-96 overexpression inhibits the apoptosis and increases tumor growth. These data suggest that microRNA-96 is a potential molecular target for glioma treatment.

Entities:  

Keywords:  PDCD4; apoptosis; glioma; microRNA-96

Mesh:

Substances:

Year:  2016        PMID: 26846266      PMCID: PMC5616120          DOI: 10.1177/1533034616629260

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  21 in total

Review 1.  The microRNA pathway and cancer.

Authors:  Pieter Bas Kwak; Shintaro Iwasaki; Yukihide Tomari
Journal:  Cancer Sci       Date:  2010-11       Impact factor: 6.716

2.  miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.

Authors:  Junfeng Zhang; Xiangjie Kong; Jia Li; Qifeng Luo; Xiaoyu Li; Lei Shen; Lei Chen; Lin Fang
Journal:  Oncol Rep       Date:  2013-12-19       Impact factor: 3.906

3.  Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

Authors:  René-Olivier Mirimanoff; Thierry Gorlia; Warren Mason; Martin J Van den Bent; Rolf-Dieter Kortmann; Barbara Fisher; Michele Reni; Alba A Brandes; Jüergen Curschmann; Salvador Villa; Gregory Cairncross; Anouk Allgeier; Denis Lacombe; Roger Stupp
Journal:  J Clin Oncol       Date:  2006-06-01       Impact factor: 44.544

4.  miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells.

Authors:  Jun-Jie Yu; Yin-Xia Wu; Fu-Jun Zhao; Shu-Jie Xia
Journal:  Med Oncol       Date:  2014-03-15       Impact factor: 3.064

5.  Inhibition of miR-96 expression reduces cell proliferation and clonogenicity of HepG2 hepatoma cells.

Authors:  Dong Xu; Xingxing He; Ying Chang; Chuanrui Xu; Xiang Jiang; Shuzhen Sun; Jusheng Lin
Journal:  Oncol Rep       Date:  2012-11-14       Impact factor: 3.906

6.  Predicting effective microRNA target sites in mammalian mRNAs.

Authors:  Vikram Agarwal; George W Bell; Jin-Wu Nam; David P Bartel
Journal:  Elife       Date:  2015-08-12       Impact factor: 8.140

Review 7.  Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge.

Authors:  Dominik Sturm; Sebastian Bender; David T W Jones; Peter Lichter; Jacques Grill; Oren Becher; Cynthia Hawkins; Jacek Majewski; Chris Jones; Joseph F Costello; Antonio Iavarone; Kenneth Aldape; Cameron W Brennan; Nada Jabado; Stefan M Pfister
Journal:  Nat Rev Cancer       Date:  2014-02       Impact factor: 60.716

Review 8.  MicroRNAs: molecular features and role in cancer.

Authors:  Elodie Lages; Helene Ipas; Audrey Guttin; Houssam Nesr; Francois Berger; Jean-Paul Issartel
Journal:  Front Biosci (Landmark Ed)       Date:  2012-06-01

9.  Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites.

Authors:  Doron Betel; Anjali Koppal; Phaedra Agius; Chris Sander; Christina Leslie
Journal:  Genome Biol       Date:  2010-08-27       Impact factor: 13.583

10.  Prognostic value of miR-96 in patients with acute myeloid leukemia.

Authors:  Jiangning Zhao; Quanyi Lu; Junfeng Zhu; Jianguo Fu; Yun-xian Chen
Journal:  Diagn Pathol       Date:  2014-03-29       Impact factor: 2.644

View more
  11 in total

1.  A Feedback Loop between MicroRNA 155 (miR-155), Programmed Cell Death 4, and Activation Protein 1 Modulates the Expression of miR-155 and Tumorigenesis in Tongue Cancer.

Authors:  Shabir Zargar; Vivek Tomar; Vidyarani Shyamsundar; Ramshankar Vijayalakshmi; Kumaravel Somasundaram; Devarajan Karunagaran
Journal:  Mol Cell Biol       Date:  2019-03-01       Impact factor: 4.272

Review 2.  Oncogenic and Tumor-Suppressive Roles of MicroRNAs with Special Reference to Apoptosis: Molecular Mechanisms and Therapeutic Potential.

Authors:  Dharambir Kashyap; Hardeep Singh Tuli; Vivek Kumar Garg; Neelam Goel; Anupam Bishayee
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

3.  Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis.

Authors:  Rui Zhang; Tian Xia
Journal:  Int J Oncol       Date:  2017-09-19       Impact factor: 5.650

4.  MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer.

Authors:  Feng Liu; Dalong Song; Yanhu Wu; Xiang Liu; Jinfu Zhu; Yihu Tang
Journal:  Thorac Cancer       Date:  2017-08-26       Impact factor: 3.500

5.  MiR-208a-3p functions as an oncogene in colorectal cancer by targeting PDCD4.

Authors:  Henglan Wu; Lele Xu; Yaou Chen; Chunfang Xu
Journal:  Biosci Rep       Date:  2019-04-16       Impact factor: 3.840

Review 6.  The Role of Micro RNAs in Regulating PI3K/AKT Signaling Pathways in Glioblastoma.

Authors:  Roshanak Ghaffarian Zirak; Hurie Tajik; Jahanbakhsh Asadi; Pedram Hashemian; Hossein Javid
Journal:  Iran J Pathol       Date:  2022-03-08

Review 7.  The Regulatory Role of Non-coding RNAs on Programmed Cell Death Four in Inflammation and Cancer.

Authors:  Mengxiang Zhao; Nisha Zhu; Fengyao Hao; Yuxian Song; Zhiyong Wang; Yanhong Ni; Liang Ding
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244

8.  Knockdown of miR-660 protects nucleus pulposus cells from TNF-a-induced apoptosis by targeting serum amyloid A1.

Authors:  Hao Jie Zhang; Xue Hai Ma; Song Lin Xie; Shu Lian Qin; Cong Zhi Liu; Zhen Guo Zhang
Journal:  J Orthop Surg Res       Date:  2020-01-06       Impact factor: 2.359

Review 9.  Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential.

Authors:  Marina Digregorio; Arnaud Lombard; Paul Noel Lumapat; Félix Scholtes; Bernard Rogister; Natacha Coppieters
Journal:  Cells       Date:  2019-11-29       Impact factor: 6.600

Review 10.  Neuroimmunomodulatory Properties of Flavonoids and Derivates: A Potential Action as Adjuvants for the Treatment of Glioblastoma.

Authors:  Ravena Pereira do Nascimento; Balbino Lino Dos Santos; Jéssika Alves Oliveira Amparo; Janaina Ribeiro Pereira Soares; Karina Costa da Silva; Monique Reis Santana; Áurea Maria Alves Nunes Almeida; Victor Diógenes Amaral da Silva; Maria de Fátima Dias Costa; Henning Ulrich; Vivaldo Moura-Neto; Giselle Pinto de Faria Lopes; Silvia Lima Costa
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.